Agrichemical company Bayer and attorneys for cancer patients have announced a proposed $7.25 billion (€6.1 billion) nationwide settlement to resolve thousands of US lawsuits.
The Germany-based company faces claims over Roundup from approximately 65,000 plaintiffs in US state and federal courts.
The lawsuits allege Bayer failed to warn people that glyphosate, the key ingredient of its popular weedkiller Roundup, causes cancer.
The plaintiffs say they developed non-Hodgkin lymphoma and other forms of cancer after using the weedkiller, either at home or on the job.
The proposed settlement announced on Tuesday calls for Bayer to make annual payments into a special fund for up to 21 years, totaling as much as $7.25 billion.
